Instrument Inactif

Autres langues Human Genome Sciences

Actions

US4449031081

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

25/07/12	GlaxoSmithKline plc : GlaxoSmithKline-T2 inférieur aux attentes, baisse du titre	RE
16/07/12	GSK rachète Human Genome pour 3,0 milliards de dollars	RE

Autres langues

03/08/12	Human Genome Sciences : ANNOUNCES REQUIRED OFFER TO REPURCHASE IN RESPECT OF ITS 3.00% CONVERTIBLE SENIOR NOTES DUE 2018
26/07/12	Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources
26/07/12	Human Genome Sciences : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Human Genome Sciences, Inc.
20/07/12	Human Genome Sciences : Law Offices of Howard G. Smith Announces Investigation of Human Genome Sciences Inc. Board of Directors for Potential Breaches of Fiduciary Duty
18/07/12	Human Genome Sciences : Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc.
17/07/12	Human Genome Sciences : Ryan & Maniskas, LLP Announces Investigation of Human Genome Sciences Inc.
16/07/12	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion
16/07/12	Human Genome Sciences : The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Human Genome Sciences, Inc. in Connection with the Sale of the Company to GlaxoSmithKline plc
16/07/12	Human Genome Sciences : GSK to acquire Human Genome Sciences for US$14.25 per share in cash
16/07/12	GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources
15/07/12	GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources
11/07/12	Human Genome Sciences : FYI From Human Genome Sciences: GlaxoSmithKline Announces Positive Data from Harmony 8 Phase 3 Trial and Completion of Clinical Registration Package for Albiglutide in Type 2 Diabetes
10/07/12	Human Genome Sciences : Announces Resubmission of Raxibacumab BLA to FDA
03/07/12	GlaxoSmithKline plc : GSK lines up nominees for Human Genome board
29/06/12	GlaxoSmithKline plc : GSK further extends $2.6 billion Human Genome offer
29/06/12	Human Genome Sciences : Responds To GSK Extension of Unsolicited Tender Offer
15/06/12	Human Genome Sciences : REPEAT/Human Genome Sciences Announces July 16 as the Date for Submission of Definitive Acquisition Proposals
15/06/12	Human Genome Sciences : Announces July 16 as the Date for Submission of Definitive Acquisition Proposals
09/06/12	Human Genome Sciences : FYI from Human Genome Sciences: GlaxoSmithKline Announces New Data from Phase 3 Studies of Once-Weekly Albiglutide in Type 2 Diabetes
08/06/12	GlaxoSmithKline plc : GSK extends its $2.6 billion offer for Human Genome
08/06/12	Human Genome Sciences : Responds to GSK Extension of Unsolicited Tender Offer
06/06/12	Human Genome Sciences : Announces Multiple Abstracts Related to BENLYSTA® and Systemic Lupus Erythematosus to Be Presented at the 2012 EULAR Annual European Congress of Rheumatology
04/06/12	Human Genome Sciences : Invites Investors to Listen to Webcast of Presentation at Goldman Sachs Conference
01/06/12	Human Genome Sciences : Response to GSK Press Release
01/06/12	GlaxoSmithKline plc : Court denies request to curb Human Genome takeover defense